Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer.
Saghir H, Veerla S, Malmberg M, Rydén L, Ehinger A, Saal LH, Vallon-Christersson J, Borg Å, Hegardt C, Larsson C, Haidar A, Hedenfalk I, Loman N, Kimbung S. Saghir H, et al. Among authors: hedenfalk i. Cancers (Basel). 2022 Aug 18;14(16):4000. doi: 10.3390/cancers14164000. Cancers (Basel). 2022. PMID: 36010992 Free PMC article.
Gene-expression profiles in hereditary breast cancer.
Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, Trent J, Raffeld M, Yakhini Z, Ben-Dor A, Dougherty E, Kononen J, Bubendorf L, Fehrle W, Pittaluga S, Gruvberger S, Loman N, Johannsson O, Olsson H, Sauter G. Hedenfalk I, et al. N Engl J Med. 2001 Feb 22;344(8):539-48. doi: 10.1056/NEJM200102223440801. N Engl J Med. 2001. PMID: 11207349 Free article.
Gene expression in inherited breast cancer.
Hedenfalk IA, Ringnér M, Trent JM, Borg A. Hedenfalk IA, et al. Adv Cancer Res. 2002;84:1-34. doi: 10.1016/s0065-230x(02)84001-5. Adv Cancer Res. 2002. PMID: 11883525 Review.
Molecular classification of familial non-BRCA1/BRCA2 breast cancer.
Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, Ach R, Loman N, Olsson H, Meltzer P, Borg A, Trent J. Hedenfalk I, et al. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2532-7. doi: 10.1073/pnas.0533805100. Epub 2003 Feb 27. Proc Natl Acad Sci U S A. 2003. PMID: 12610208 Free PMC article.
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier.
Johannsson OT, Staff S, Vallon-Christersson J, Kytöla S, Gudjonsson T, Rennstam K, Hedenfalk IA, Adeyinka A, Kjellén E, Wennerberg J, Baldetorp B, Petersen OW, Olsson H, Oredsson S, Isola J, Borg A. Johannsson OT, et al. Lab Invest. 2003 Mar;83(3):387-96. doi: 10.1097/01.lab.0000060030.10652.8c. Lab Invest. 2003. PMID: 12649339 Free article.
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
Strand C, Bak M, Borgquist S, Chebil G, Falck AK, Fjällskog ML, Grabau D, Hedenfalk I, Jirström K, Klintman M, Malmström P, Olsson H, Rydén L, Stål O, Bendahl PO, Fernö M. Strand C, et al. Among authors: hedenfalk i. Springerplus. 2013 Dec;2(1):111. doi: 10.1186/2193-1801-2-111. Epub 2013 Mar 14. Springerplus. 2013. PMID: 23560250 Free PMC article.
79 results